Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Patrick M Meyer Sauteur

Has grant

Consultant (mbF) and Research Group Leader (experimental and clinical Infectious Diseases)

University Children's Hospital Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Epidemiology Epidemiology professors in Switzerland

Recent Grants

Grant: Close

SSI Award 2025

Open Date: 2025-01-01

Close Date: 2025-01-01

Grant: Close

Developing a novel method for assessing global genetic diversity and molecular surveillance of Mycoplasma pneumoniae during its re-emergence after the COVID-19 pandemic and beyond

Open Date: 2024-07-01

Close Date: 2026-01-01

Grant: Close

EMDO Foundation Grant 2024

Open Date: 2024-01-01

Close Date: 2024-12-01

Grant: Close

Derrick Edward Award — Recognition for outstanding research in mycoplasmology

Open Date: 2024-01-01

Close Date: 2024-01-01

Grant: Open

A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia (CAP): THE MYTHIC STUDY

Open Date: 2023-01-01

Close Date: 2027-12-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (17)

Michael Huber

Head Diagnostics and Development

University of Zurich

SWITZERLAND

Patrick M Meyer Sauteur

Research Interests

Explore related searches

Recent Grants

Articles (20)

Clinical Features and Outcomes of Pediatric Lyme Arthritis in Europe: A Large Swiss Cohort Study

Streamlining<i> Borrelia</i><i> burgdorferi</i> cultivation using quantitative PCR screening

Bacterial respiratory infections in children: advances in diagnostic strategies

Beyond the Target: Re‐Emergence of Mycoplasma pneumoniae Supports Reclassification of Adult Mucocutaneous Eruptions

Evaluation of the ELITe InGenius PCR assay compared with immunofluorescence for Pneumocystis jirovecii detection in respiratory samples

Improving prediction of future Mycoplasma pneumoniae epidemics using data-driven transmission models

Doxycycline’s stains

Age-specific trends in the prescription of systemic antibiotics, 2010–2024

Mykoplasmen-Infektionen

Pneumonie

Surge in macrolide dispensing to Swiss children in a period of increased incidence of Mycoplasma pneumoniae detection: an interrupted time-series analysis

Mycoplasma pneumoniae: Extrapulmonary Manifestations in Children With Focus on Mucocutaneous Disease

Evolving clinical features of Mycoplasma pneumoniae infections following COVID-19 pandemic restrictions: a retrospective, comparative cohort study

Epidemiological changes in Chlamydia pneumoniae molecular detections before, during and after the COVID-19 pandemic in 27 European sites and Taiwan, 2018 to 2023

Recurrent vaccine-strain varicella zoster virus reactivation in a child with acute lymphatic leukemia

Mycoplasma pneumoniae re-emergence: clinical features revisited

Mycoplasma pneumoniae: re-emergence and beyond

Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities

Mycoplasma pneumoniae re-emergence in 2023 causes disease in adults in Europe

Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study

Collaborators (17)

Michael Huber

C.T. Berger

Claudia Del Vecchio

francois angoulvant

Alberto Rizzo

Ioannis Kopsidas

Michele Ramien

Adrian Egli

Petra Zimmermann

Stephen Jenkinson

Lilliam Ambroggio

Manon Jaboyedoff

Mirja Puolakkainen

Oliver Nolte

Michelle Seiler

Stefanie von Felten

Noémie Boillat-Blanco

Make your next move.